Publication | Closed Access

The VAD chemotherapy regimen plus a G-CSF dose of 10 μg/kg is as effective and less toxic than high-dose cyclophosphamide plus a G-CSF dose of 5 μg/kg for progenitor cell mobilization: results from a monocentric study of 82 patients

Hematological MalignancyOncologyMedicineMetronomic TherapyHematologyImmunologyVad Chemotherapy RegimenG-csf DosePharmacotherapyCancer TreatmentPharmacologyRadiation OncologyMonocentric StudyCancer ResearchHealth Sciences